Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Clinical insights
Key research benefits
A 28-amino-acid thymic peptide approved in 35+ countries (as Zadaxin) for chronic hepatitis and as a cancer-therapy adjunct — one of the most studied peptides in this guide.
- 86% viral DNA clearance vs. 20% with placebo in a controlled hepatitis B trial.
- Cut flu incidence from 19% to 6% in a 90-patient elderly trial while boosting vaccine antibody response.
- Cancer adjunct data linked to a median survival of 38.4 months vs. 8 months when added to checkpoint-inhibitor therapy in a melanoma trial.
Research backing
Over 11,000 human subjects across 30+ trials — the deepest human evidence base in this guide. Note: the large 2025 BMJ TESTS sepsis trial (n=1,089) found no mortality benefit, illustrating that effect sizes shrink in the largest, highest-quality trials.
Research Grade Formula
Thynosin Alpha-1
Healing & Recovery
Thynosin Alpha-1 · 10mg
$120
Express Shipping $20 — Australia only
- Third-party tested
- Non-GMO
- GMP certified
How to use
Follow research handling and reconstitution guidance for this compound. Always use appropriate lab technique and sterile materials.
Research Dosage ProtocolWhat's inside
This unit contains Thymosin Alpha-1, an immunomodulatory research peptide studied in host-response and innate-immunity models. Supplied lyophilized for accurate laboratory preparation.
Technical overview
- Contents: Thymosin Alpha-1 research peptide, 10 mg class vial
- Class: Thymic peptide fragment used in immune-pathway research
- Purity: ≥99% with Certificate of Analysis support
- Appearance: White to off-white lyophilized powder
- Handling: Reconstitute aseptically with bacteriostatic water
- Storage: Keep sealed and dry until use; refrigerate after mixing
Reconstitute with bacteriostatic water at room temperature. For laboratory research and educational use only — not for human consumption.
Customer reviews
4.9
Based on 312 reviews
